Skip to content

Evaluation of Pulpotomy Using Two Different Agents in Mature Anterior Teeth With Pulpitis

Clinical and Radiographic Evaluation of Premixed Bioceramic Putty and Biodentine™ Pulpotomy in Mature Permanent Anterior Teeth With Signs of Pulpitis: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06468085
Enrollment
48
Registered
2024-06-21
Start date
2024-07-01
Completion date
2026-07-01
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpitis

Brief summary

the study will evaluate the clinical and radiological success of mature permanent anterior teeth pulpotomy in children and adolescents with signs of pulpitis using two different Biomimetic materials (NeoPutty® and Biodentine™) as a pulp dressing material in comparison to root canal treatment at 3, 6, 9 and 12 months follow up.

Detailed description

In this randomized controlled trial, A total number of 75 mature vital permanent anterior teeth with recent trauma or deep caries in children aged between 9 and 14 years will be included. Patients will be randomly allocated into three study groups: group A (premixed bioceramic NeoPutty®) test group, group B (Biodentine™) test group and group C (root canal treatment) control group. Cases will be evaluated clinically and radiographically to obtain baseline data. Local anesthesia will be administered and then rubber dam isolation will be performed. Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic or Biodentine™ according to the corresponding group then final composite restoration will be applied. Root canal treatment will be performed to the control group followed by composite restoration. Blinded clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

Interventions

PROCEDUREpremixed Bioceramic NeoPUTTY®

Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic then final composite restoration will be applied. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

PROCEDUREBiodentine™

Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic or Biodentine™ according to the corresponding group then final composite restoration will be applied. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

PROCEDURERoot canal treatment

Root canal treatment will be performed to the control group followed by composite restoration. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Double Blind study, where participants will be blinded to the study groups they are randomized to, statisticians will be blinded while performing statistical analysis. On the other hand, the operator/primary investigator cannot be blinded as she is already familiar with the tooth and materials used and their different application. Also, the outcome assessor is not blinded due to the difference between the used materials.

Intervention model description

two study groups and one control group

Eligibility

Sex/Gender
ALL
Age
9 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Children and adolescents of both sexes aged between 9 and 14 years old. * Vital mature permanent anterior teeth with deep caries lesions that approach the pulp with signs of pulpitis and respond positive to cold pulp testing. * Vital mature permanent anterior teeth with pulpal exposure that occurred during caries excavation. * Patients presented immediately after suffering recent trauma (at the same day) to mature anterior teeth that had resulted in a crown fracture with pulp exposure.

Exclusion criteria

* Teeth with signs of infection such as swelling, sinus tract or pathological mobility or excessive mobility. * Teeth with excessive bleeding from amputated radicular stumps * Teeth showing radiographic evidence of pathologic root resorption, periapical pathology and calcifications in the canals. * Lack of patient/parent compliance and cooperation. * Children who are physically or mentally disabled or having any medical condition that will complicate the treatment. * Patients allergic to any medicaments used.

Design outcomes

Primary

MeasureTime frameDescription
Clinical success3, 6, 9 and 12 months follow upAbsence of pain related to the treated teeth, including patient reported pain or sensitivity to percussion/palpation. No evidence of swelling of supporting soft tissue or presence of sinus tract. Absence of excessive mobility affecting treated teeth.
Radiographic success3, 6, 9 and 12 months follow upNo Internal or external root resorption. No Periapical radiolucency.

Secondary

MeasureTime frameDescription
Evaluation of tooth discoloration.3, 6, 9 and 12 months follow upEvaluation of tooth discoloration using the VITA Easyshade V digital spectrophotometer.

Contacts

Primary ContactSally Emad, BDS,MSc
sallyghobrial@dent.asu.edu.eg01227788137
Backup ContactDina Darwish, BDS,MSc, MD
dinadarwish@dent.asu.edu.eg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026